(Q55071550)

17 June 2018

title

The alteration of Hippo/YAP signaling in the development of hypertrophic cardiomyopathy. (English)

1 reference

17 June 2018

author name string

Pei Wang

1

1 reference

17 June 2018

Beibei Mao

2

1 reference

17 June 2018

Wen Luo

3

1 reference

17 June 2018

Bin Wei

4

1 reference

17 June 2018

Wenjian Jiang

5

1 reference

17 June 2018

Dong Liu

6

1 reference

17 June 2018

Lei Song

7

1 reference

17 June 2018

Guangju Ji

8

1 reference

17 June 2018

Zhongzhou Yang

9

1 reference

17 June 2018

Yong-Qiang Lai

10

1 reference

17 June 2018

Zengqiang Yuan

11

1 reference

17 June 2018

publication date

29 August 2014

1 reference

17 June 2018

Basic Research in Cardiology

published in

1 reference

17 June 2018

volume

109

1 reference

17 June 2018

issue

5

1 reference

17 June 2018

page(s)

435

1 reference

17 June 2018

https://scigraph.springernature.com/pub.10.1007/s00395-014-0435-8

exact match

0 references

cites work

The delta isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload

1 reference

https://api.crossref.org/works/10.1007%2FS00395-014-0435-8

CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-014-0435-8

Alpha-myosin heavy chain: a sarcomeric gene associated with dilated and hypertrophic phenotypes of cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-014-0435-8

JNK modulates FOXO3a for the expression of the mitochondrial death and mitophagy marker BNIP3 in pathological hypertrophy and in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-014-0435-8

Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-014-0435-8

Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-014-0435-8

Proapoptotic Rassf1A/Mst1 signaling in cardiac fibroblasts is protective against pressure overload in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-014-0435-8

Therapeutic options in minimizing left ventricular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-014-0435-8

Missense mutations in the beta-myosin heavy-chain gene cause central core disease in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-014-0435-8

Angiotensin-(1-9) attenuates cardiac fibrosis in the stroke-prone spontaneously hypertensive rat via the angiotensin type 2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-014-0435-8

Decoding calcium signals involved in cardiac growth and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-014-0435-8

Decreased metalloprotease 9 induction, cardiac fibrosis, and higher autophagy after pressure overload in mice lacking the transcriptional regulator p8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-014-0435-8

Role for G(12)/G(13) in agonist-induced vascular smooth muscle cell contraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-014-0435-8

Regulation of cardiac stress signaling by protein kinase d1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-014-0435-8

Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-014-0435-8

Limitations of the difference between clinic and daytime blood pressure as a surrogate measure of the ‘white-coat’ effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-014-0435-8

Extracellular signal-regulated kinase 1/2 (ERK1/2) signaling in cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-014-0435-8

Protein kinase Cα as a heart failure therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-014-0435-8

Cardiac hypertrophy: targeting Raf/MEK/ERK1/2-signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-014-0435-8

CaMKII negatively regulates calcineurin-NFAT signaling in cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-014-0435-8

Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-014-0435-8

Lats2 is a negative regulator of myocyte size in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-014-0435-8

Transient cardiac expression of constitutively active Galphaq leads to hypertrophy and dilated cardiomyopathy by calcineurin-dependent and independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-014-0435-8

Cardiac hypertrophy and heart failure development through Gq and CaM kinase II signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-014-0435-8

A calcineurin-dependent transcriptional pathway for cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-014-0435-8

Alpha1-adrenergic receptors prevent a maladaptive cardiac response to pressure overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-014-0435-8

Hippo signaling in organ size control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-014-0435-8

Akt activation promotes degradation of tuberin and FOXO3a via the proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-014-0435-8

Akt/protein kinase B promotes organ growth in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-014-0435-8

Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-014-0435-8

YAP mediates crosstalk between the Hippo and PI(3)K–TOR pathways by suppressing PTEN via miR-29

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-014-0435-8

Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-014-0435-8

YAP1, the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-014-0435-8

The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-014-0435-8

TEAD mediates YAP-dependent gene induction and growth control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-014-0435-8

Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-014-0435-8

Prevention of Cardiac Hypertrophy in Mice by Calcineurin Inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-014-0435-8

10.1007/S00395-014-0435-8

21 January 2018

Identifiers

DOI

1 reference

17 June 2018

Dimensions Publication ID

1011532469

0 references

1 reference

17 June 2018